The Global PET-CTScanner Device Market, by Detector Type (FluroDeoxyGlucose, 62CU ATSM,FMISO, Gallium, Thallium, and Others), by Setting (Fixed and Portable), byApplication (Cardiology, Neurology, Oncology, and Others), by End User(Hospitals, Diagnostic Centers, and Research Institutes), and by Region (NorthAmerica, Latin America, Europe, Asia Pacific, Middle East, and Africa) wasvalued at US$ 1.9 billion in 2017, and is projected to exhibit a CAGR of 5.1%over the forecast period (2018 - 2026).
Reduction in price of PET-CTscanners, increasing incidence of cancer, and rising clinical applications ofthese devices are expected to drive the PET-CT scanner device market growthover the forecast period. According to the American Cancer Society, cancerincidence rates increased in children and adolescents by 0.6% per year since1975. Cancer is the second most common cause of death among children of age 1to 14 years in the U.S., after accidents. In 2018, an estimated 10,590 childrenof this age group are expected to be diagnosed with cancer. Furthermore,continued development of new radiotracers is expected to drive demand forPET-CT scanners in clinical applications such as oncology, Alzheimer's diseaseand others.
Technological advancements inthese devices include introduction of features such as high image contrast andresolution, removal of metal artifacts, improved large field-of-view imaging,and others. In 2017, Toshiba Medical launched new Celesteion PUREViSION EditionPET-CT system to help diagnose and treat oncology patients. It offers 70 cmtrue field-of-view, and SUREFLiGHT reconstruction technology, including Time ofFlight and Point Spread Function techniques, and offers high contrast and sharpimages to the oncologists for improved visualization of small tumors.
* The sample copy includes: Report Summary, Table ofContents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copyof this report: https://www.coherentmarketinsights.com/insight/request-sample/2169
Major advantages of the PET-CTinclude better localization of activity to normal versus abnormal structures,better identification of inflammatory lesions, overall decreased scan time,discovery of serendipitous abnormalities, CT visualization of PET-negativelesions, confirmation of abnormal or unusual sites, and improved localizationfor radiotherapy or biopsy. Characterization and localization of lesions toconfirm or exclude malignancy is a very important aspect of these devices.
Browse 24 Market Data Tables and29 Figures spread through 172 Pages and in-depth TOC on "PET-CT ScannerDevice Market, by Detector Type (FluroDeoxyGlucose, 62CU ATSM, FMISO, Gallium,Thallium, and Others), by Setting (Fixed and Portable), by Application(Cardiology, Neurology, Oncology, and Others), by End User (Hospitals,Diagnostic Centers, and Research Institutes), and by Region (North America,Latin America, Europe, Asia Pacific, Middle East, and Africa) - Global Forecastto 2026"
Manufacturers in the PET-CTscanner device market are focusing on the development of technologicallyadvanced and low price devices. For instance, in 2016, Neusoft Medical Systems,a Chinese medical device manufacturer, launched NeuSight PET-CT scanners,globally. NeuSight PET/CT device received FDA approval in the U.S. and CE Markapproval in the European Union in 2015. The device offers high qualitydiagnostic images with fast processing speeds. High price of these devices wasone of the major factors hindering the imaging centers from purchasing PET-CTscanners in previous years. In 2013, the cost of PET-CT machines was around US$3 million. However, in recent years, price for PET-CT scanners have reduced toUS$ 1.5 million for entry-level machines, as vendors have developed lower-costoptions.
Browse ResearchReport: https://www.coherentmarketinsights.com/market-insight/pet-ct-scanner-device-market-2169
Key Takeaways of the PET-CTScanner Device Market:
The global PET-CT scanner devicemarket is expected to expand at a CAGR of 5.1% during the forecast period(2018–2026), since the PET-CT combination allows for both the structure and thebiochemical processes to be shown in an image, which increased the demand forPET-CT in oncology
Among application, oncologysegment is expected to account for major revenue share in 2018, owing toincreasing prevalence of various types of cancer. According to the American CancerSociety 2018 report, in 2018, the overall estimated cancer cases are 1,735,350,which is over 4,700 new cancer diagnosis daily.
Major players operating in theglobal PET-CT scanner device market include General Electric Co., Hitachi,Ltd., Mediso Ltd., Koninklijke Philips N.V., PerkinElmer, Inc., PositronCorporation, Siemens AG, Shimadzu Corporation, Toshiba Corporation, andYangzhou Kindsway Biotech Co. Ltd.
Buy-Now this researchreport: https://www.coherentmarketinsights.com/insight/buy-now/2169
AboutCoherent Market Insights:
CoherentMarket Insights is a prominent market research and consulting firm offeringaction-ready syndicated research reports, custom market analysis, consultingservices, and competitive analysis through various recommendations related toemerging market trends, technologies, and potential absolute dollaropportunity.
ContactUs:
mailto:sales@coherentmarketinsights.com
U.S.Office:
Name: Mr. Shah
CoherentMarket Insights 1001 4th Ave,
# 3200Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN : +050-5539-1737
